4.4 Article

Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells

Related references

Note: Only part of the references are listed.
Article Oncology

Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastoma

Jintao Gu et al.

Summary: This study presents a novel preclinical model for radiobiological studies and identifies a radiation-tolerant persister subpopulation that drives radioresistance by activating DNA damage repair and promoting stemness. The NF-kappa B-YY1-miR-103a regulatory axis is essential for the function of the radiation-tolerant persister cells. Furthermore, transferrin-functionalized nanoparticles improve radiosensitivity and provide a significant survival benefit.

NEURO-ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Chronically Radiation-Exposed Survivor Glioblastoma Cells Display Poor Response to Chk1 Inhibition under Hypoxia

Nareg Pinarbasi-Degirmenci et al.

Summary: By applying fractionated radiotherapy over a long time and selecting irradiation-survivor glioblastoma cells, clinically relevant irradiation-exposed models were generated. The cells exhibited slower growth, resistance to secondary irradiation, upregulation of DDR-related genes, and better DNA repair capacity. The utility of combining DDR inhibitors and irradiation was demonstrated for both naive and IR-Surv glioblastoma cells, as long as cells are refrained from hypoxic conditions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

High levels of NRF2 sensitize temozolomide-resistant glioblastoma cells to ferroptosis via ABCC1/MRP1 upregulation

I de Souza et al.

Summary: The study reveals the role of NRF2 in modulating ferroptosis in glioblastoma cells, as well as its correlation with ABCC1 expression. Moreover, high levels of NRF2 result in collateral sensitivity and contribute to GSH depletion when the system xc(-) is blocked. These findings suggest that ferroptosis induction could be a potential therapeutic strategy to reverse drug resistance in gliomas.

CELL DEATH & DISEASE (2022)

Review Oncology

Pharmacological targets for the induction of ferroptosis: Focus on Neuroblastoma and Glioblastoma

Luciano Ferrada et al.

Summary: The article summarizes the challenges and needs for the treatment of neuroblastomas and glioblastomas and introduces a new type of cell death called ferroptosis, which has potential applications in the treatment of these tumors.

FRONTIERS IN ONCOLOGY (2022)

Article Oncology

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019

Quinn T. Ostrom et al.

Summary: The report provides the latest data on primary brain tumors in the United States, including incidence rates, mortality rates, and relative survival rates. The overall incidence rate is higher in females and non-Hispanic population, and glioblastoma is the most common malignant brain tumor, while meningioma is the most common non-malignant brain tumor. The relative survival rate is lower for malignant brain tumors and higher for non-malignant brain tumors.

NEURO-ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges

Shenghua Zhuo et al.

Summary: Glioblastoma (GBM) is a common malignant brain tumor with high heterogeneity and an immunosuppressive microenvironment, making its treatment difficult. Ferroptosis, a newly discovered non-apoptotic cell death process, plays a crucial role in GBM therapies. Targeting ferroptosis may be an effective strategy to overcome resistance to tumor therapy and immune escape mechanisms.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Article Medicine, General & Internal

Ferroptosis Involvement in Glioblastoma Treatment

Andrei-Otto Mitre et al.

Summary: Glioblastoma multiforme (GBM) is a deadly brain tumor with limited treatment options. Stimulation of ferroptosis, a form of cell death, has been found to inhibit GBM growth and improve patient survival.

MEDICINA-LITHUANIA (2022)

Article Cell Biology

RSL3 Drives Ferroptosis through NF-κB Pathway Activation and GPX4 Depletion in Glioblastoma

Shengbiao Li et al.

Summary: The study revealed that RSL3 induced ferroptosis in glioblastoma cells by increasing lipid ROS concentration and downregulating ferroptosis-related proteins. Activation of the NF-kappa B pathway by RSL3 played a key role in this process, and inhibition of this pathway alleviated ferroptosis. Furthermore, the combination of NF-kappa B pathway activation and GPX4 silencing effectively induced ferroptosis in glioblastoma cells, suggesting a potential therapeutic strategy for glioblastoma treatment.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Review Cell Biology

Ferroptosis, radiotherapy, and combination therapeutic strategies

Guang Lei et al.

Summary: Ferroptosis, an iron-dependent form of regulated cell death, plays an important role in radiotherapy-induced cell death and tumor suppression, mediating synergy with immunotherapy. This review summarizes the crosstalk between radiotherapy and ferroptosis, and explores combination therapeutic strategies.

PROTEIN & CELL (2021)

Article Oncology

The ever-increasing importance of cancer as a leading cause of premature death worldwide

Freddie Bray et al.

Summary: CVD and cancer are now leading causes of premature death in 127 countries with cancer poised to overtake CVD in most countries over the course of this century. Governments must consider these transitions in disease profiles when developing cancer policies at the local level.

CANCER (2021)

Article Medicine, Research & Experimental

SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis

Lei Feng et al.

Summary: This study revealed a connection between high expression of SLC7A11 and nuclear expression of NRF2 in patients with ESCC, which was associated with worse survival rates and poorer treatment outcomes. SLC7A11-mediated ferroptosis inhibition induced NRF2-associated radioresistance.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Article Oncology

FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma

Xin Zhang et al.

Summary: FIN56, a novel ferroptosis inducer, showed promising anti-tumor effects on glioblastoma cells by inducing ferroptosis and lysosomal membrane permeabilization in a ferroptosis and transfactor EB dependent manner. Animal study confirmed the inhibitory effect of FIN56 on glioma growth in vivo.

JOURNAL OF CANCER (2021)

Article Biochemistry & Molecular Biology

Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers

Ling F. Ye et al.

ACS CHEMICAL BIOLOGY (2020)

Article Cell Biology

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression

Han-jie Liu et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Oncology

Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance

Sara M. Elgendy et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

Review Oncology

Ferroptosis, a new form of cell death: opportunities and challenges in cancer

Yanhua Mou et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Editorial Material Cell Biology

A Physiological Function for Ferroptosis in Tumor Suppression by the Immune System

Brent R. Stockwell et al.

CELL METABOLISM (2019)

Article Chemistry, Multidisciplinary

Recent Progress in Ferroptosis Inducers for Cancer Therapy

Chen Liang et al.

ADVANCED MATERIALS (2019)

Article Biochemistry & Molecular Biology

RSL3 induced autophagic death in glioma cells via causing glycolysis dysfunction

Xuanzhong Wang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Review Chemistry, Multidisciplinary

Emerging Strategies of Cancer Therapy Based on Ferroptosis

Zheyu Shen et al.

ADVANCED MATERIALS (2018)

Article Biochemistry & Molecular Biology

Targeting Dependency on the GPX4 Lipid Peroxide Repair Pathway for Cancer Therapy

Hengrui Liu et al.

BIOCHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis

Valerian E. Kagan et al.

NATURE CHEMICAL BIOLOGY (2017)

Article Clinical Neurology

P01.15 Mitochondrial poisoning as a novel therapy for glioblastoma

N. Gomez-Roman et al.

NEURO-ONCOLOGY (2017)

Article Multidisciplinary Sciences

Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis

Wan Seok Yang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Cell Biology

Ferrootosis: Death by Lipid Peroxidation

Wan Seok Yang et al.

TRENDS IN CELL BIOLOGY (2016)

Review Oncology

Radiotherapy and the tumor stroma: the importance of dose and fractionation

Turid Hellevik et al.

FRONTIERS IN ONCOLOGY (2014)

Article Biochemistry & Molecular Biology

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Scott J. Dixon et al.

Review Oncology

Dying cell clearance and its impact on the outcome of tumor radiotherapy

Kirsten Lauber et al.

FRONTIERS IN ONCOLOGY (2012)

Review Oncology

p53-a Jack of all trades but master of none

Melissa R. Junttila et al.

NATURE REVIEWS CANCER (2009)

Article Multidisciplinary Sciences

RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels

Nicholas Yagoda et al.

NATURE (2007)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Biology

Radiation-induced peroxidation and fragmentation of lipids in a model membrane

OI Shadyro et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2002)